Zobrazeno 1 - 10
of 168
pro vyhledávání: '"J. Sennesael"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marie Stiborová, Jacques J. Sennesael, Heinz H Schmeiser, David H. Phillips, Gonçalo Gamboa da Costa, Elisabeth Cassuto-Viguier, Damien Ambrosetti, Volker M. Arlt, Agnieszka Pozdzik, Sandrine Rorive, Rajinder Singh, Joëlle Nortier
Publikováno v:
International Journal of Cancer. 135:502-507
Aristolochic acid (AA) causes aristolochic acid nephropathy (AAN), first described in women in Belgium accidently prescribed Aristolochia fangchi in a slimming treatment, and also Balkan endemic nephropathy (BEN), through probable dietary contaminati
Autor:
Klemens Budde, J.L. Bosmans, Martin Zeier, Przemyslaw Pisarski, W. Fischer, Manuela Schütz, J. Sennesael, Petra Glander, Hans-H. Neumayer
Publikováno v:
Nieren- und Hochdruckkrankheiten. 36:211-224
Autor:
Petra Glander, Manuela Schütz, Martin Zeier, J. Sennesael, W. Fischer, Przemyslaw Pisarski, Klemens Budde, H.-H. Neumayer, J.L. Bosmans
Publikováno v:
Clinical nephrology
Background: The lower limit of exposure to calcineurin inhibitors has not yet been established in de novo renal transplant patients receiving mycophenolic acid therapy with basiliximab. Methods: A 12-month, multicenter, randomized, open-label trial w
Publikováno v:
Vrije Universiteit Brussel
The effect of two different dialysate solutions with a calcium concentration of 1.25 and 1.75 mmol/l was evaluated in 14 patients, using a cross-over design. Patients were treated with each solution during a period of 6 months. Treatment with calcium
Autor:
J.P. Fillastre, J. Sennesael, F. Mignon, A. Meyrier, M. Aparicio, N. El Esper, B. Levaltier, Jean-Philippe Ryckelynck, M. Dratwa, R. Lins
Publikováno v:
The American journal of cardiology
The pharmacokinetics of rilmenidine (1 mg orally) was studied in 3 groups of patients with stable chronic renal insufficiency. This was an open, single-blind study following a single administration, and after 15 days of treatment. Group 1 included 11
Publikováno v:
Transplantation proceedings. 43(9)
Background. Abnormalities in bone and mineral metabolism are common after renal transplantation (RT) but information on their long-term time course is scarce. Objectives. (1) Evaluate the time course of biochemical parameters of bone and mineral meta
Background. The occurrence and risk factors for posterior subcapsular cataract (PSC) after renal transplantation have received little attention. Objectives. To analyze the cumulative incidence of PSC after renal transplantation and identify risk fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e291a328bf80a8c51343572d5176b675
https://hdl.handle.net/20.500.14017/c8ef70e6-9dff-4d48-88f2-3747560743fa
https://hdl.handle.net/20.500.14017/c8ef70e6-9dff-4d48-88f2-3747560743fa
Publikováno v:
Transplantation proceedings. 42(10)
Background Posttransplantation diabetes mellitus (PTDM) is a seious complication of transplantation which is caused by immunosuppressive drugs and adversely affects the survival of the transplant recipient and the long-term survival of the graft. In